News & Press: Latest News

MDMA Announces Volcano President and CEO as New Chairman

Thursday, May 22, 2014  
Share |

WASHINGTON, DC – The Medical Device Manufacturers Association (MDMA) announced today that Scott Huennekens, President and CEO of Volcano Corporation, was unanimously chosen as the new Chairman of the MDMA Board of Directors during the 2014 Annual Meeting.


“We know that medical technology innovators can lead the way towards providing better patient care, while driving down costs, but we need to ensure that the proper incentives are in place to foster the risk-taking and sacrifices that make this ecosystem so strong,” said Chairman Huennekens.  “It’s an honor to work in such a passionate industry whose central goal is to alleviate human suffering, and I look forward to working with our members and the entire MDMA team to make sure our industry continues to deliver on the promises of a better tomorrow.”  


Huennekens follows the successful two-year tenure of Dan Moore, President and CEO of Cyberonics, Inc.  He noted that his goals are to build on the momentum to repeal the medical device tax, ensure MDUFA milestones are being met, and to fight for a more fair and adequate reimbursement system for medical technologies.


“MDMA continues to be at the forefront fighting for medical device entrepreneurs and innovators as they seek to improve patient care and bring cutting-edge technologies to the marketplace,” said Mark Leahey, President and CEO of MDMA.  “Scott embodies the passion and dedication that drives our members and the entire medical technology industry, and under his leadership we will continue to protect and grow America’s leadership position in this vibrant field.”


The MDMA Board of Directors also added two new members to the board.  They are:

·      Doug Godshall, President and CEO, HeartWare, Inc.

·      Jeff McCaulley, President, Smiths Medical


“There is no shortage of challenges facing medical technology innovators today, and MDMA will continue its proud tradition of passionate advocacy to confront them all head-on,” added Leahey.


###